- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
ERIS Lifesciences Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
| Financial Year | |||||
|---|---|---|---|---|---|
731.67 | 745.72 | 721.36 | 566.07 | 490.49 | |
| Other Income Qtr Cr | 4.22 | 6.77 | 1.64 | 15.15 | 4.20 |
| Operating Revenues Qtr | 727.45 | 738.95 | 719.72 | 550.92 | 486.30 |
*All values are in Cr. | |||||
477.14 | 476.66 | 469.73 | 402.49 | 310.79 | |
250.31 | 262.29 | 249.99 | 148.43 | 175.51 | |
254.53 | 269.06 | 251.63 | 163.58 | 179.71 | |
81.20 | 80.48 | 75.94 | 53.90 | 45.72 | |
83.63 | 91.59 | 83.18 | 70.96 | 102.74 | |
6.15 | 6.73 | 6.11 | 5.22 | 7.55 | |
Open Demat Account
Open Demat Account